{"id":32358,"date":"2018-08-13T12:00:00","date_gmt":"2018-08-13T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/"},"modified":"2018-08-13T12:00:00","modified_gmt":"2018-08-13T12:00:00","slug":"positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/","title":{"rendered":"Positionering van Dymista bij de behandeling van allergische rhinitis"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1378 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Brussel 2017<\/h2>\n<p>Debat over de positionering van Dymista, een nasale behandeling voor allergische rhinitis. Dymista is een symptomatische behandeling die een antihistaminicum (azelastine) en een corticostero\u00efd (fluticasonpropionaat) bevat. <\/p>\n<h3>Panelleden<\/h3>\n<p>dr. David Price, dr. Glenis Scadding, dr. Emmanuel Prokopakis, dr. Wytske Fokkens, dr. Oliver Pfaar, dr. Peter Hellings, dr. Claus Bachert en dr. Jean Bousquet.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1379 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/_GuPUayz1hs?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Brussel 2017 Debat over de positionering van Dymista, een nasale behandeling voor allergische rhinitis. Dymista is een symptomatische behandeling die een antihistaminicum (azelastine) en een corticostero\u00efd (fluticasonpropionaat) bevat. Panelleden dr. David Price, dr. Glenis Scadding, dr. Emmanuel Prokopakis, dr. Wytske Fokkens, dr. Oliver Pfaar, dr. Peter Hellings, dr. Claus Bachert en dr. Jean Bousquet.<\/p>\n","protected":false},"author":1,"featured_media":32378,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[233],"tags":[234,235,236,164,223],"class_list":["post-32358","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-rhinologie","tag-debatten","tag-rhinology-future-debates","tag-allergische-rhinitis-ar","tag-astma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Positionering van Dymista bij de behandeling van allergische rhinitis - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positionering van Dymista bij de behandeling van allergische rhinitis\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Brussel 2017 Debat over de positionering van Dymista, een nasale behandeling voor allergische rhinitis. Dymista is een symptomatische behandeling die een antihistaminicum (azelastine) en een corticostero\u00efd (fluticasonpropionaat) bevat. Panelleden dr. David Price, dr. Glenis Scadding, dr. Emmanuel Prokopakis, dr. Wytske Fokkens, dr. Oliver Pfaar, dr. Peter Hellings, dr. Claus Bachert en dr. Jean Bousquet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/\",\"name\":\"Positionering van Dymista bij de behandeling van allergische rhinitis - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"datePublished\":\"2018-08-13T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Positionering van Dymista bij de behandeling van allergische rhinitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Positionering van Dymista bij de behandeling van allergische rhinitis - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/","og_locale":"nl_NL","og_type":"article","og_title":"Positionering van Dymista bij de behandeling van allergische rhinitis","og_description":"Rhinology Future Debates Brussel 2017 Debat over de positionering van Dymista, een nasale behandeling voor allergische rhinitis. Dymista is een symptomatische behandeling die een antihistaminicum (azelastine) en een corticostero\u00efd (fluticasonpropionaat) bevat. Panelleden dr. David Price, dr. Glenis Scadding, dr. Emmanuel Prokopakis, dr. Wytske Fokkens, dr. Oliver Pfaar, dr. Peter Hellings, dr. Claus Bachert en dr. Jean Bousquet.","og_url":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/","url":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/","name":"Positionering van Dymista bij de behandeling van allergische rhinitis - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","datePublished":"2018-08-13T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/positionering-van-dymista-bij-de-behandeling-van-allergische-rhinitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/nl\/news\/"},{"@type":"ListItem","position":3,"name":"Positionering van Dymista bij de behandeling van allergische rhinitis"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/nl\/#website","url":"https:\/\/www.euforea.org\/nl\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/nl\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/32358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=32358"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/32358\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/32378"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=32358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=32358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=32358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}